Jade PTA Balloon Dilatation Catheter 585015022Recalls & reported problems
OrbusNeich Medical (ShenZhen) Co., Ltd. · Percutaneous Transluminal Angioplasty (PTA) Catheter · Class 2
All models of Jade PTA Balloon Dilatation Catheter (15)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 1
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 06934955901270), received between Mar 29, 2025 and Apr 4, 2025 — classified as 1 injury, 1 malfunction.
The most frequently reported specific device problem is “Material Rupture” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Most reported problems
Device problems
- Material Rupture1
- Material Separation1
- Material Split, Cut or Torn1
Patient problems
- Foreign Body In Patient2
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryApr 4, 2025Material Rupture; Material Separation; Material Rupture; Material Separation
IT WAS REPORTED THAT A NON-DILATABLE, HEAVILY CALCIFIED, HEAVILY TORTUOUS SUPERFICIAL FEMORAL ARTERY WITH CHRONIC TOTAL OCCLUSION WAS ATTEMPTED TO BE TREATED WITH SEVERAL UNSPECIFIED BALLOONS, ALL UNSUCCESSFULLY. WHEN A JADE PTA OTW 5 X 150 MM BALLOON WAS ATTEMPTED TO BE USED, IT RUPTURED WHEN IT REACHED ROUGHLY 22-24 ATMOSPHERES. THE RUPTURED COMPONENT CAME ENTIRELY OFF THE SHAFT. THERE WAS A DELAY OF A FEW HOURS WHILE THE PHYSICIAN PLACED STENTS. ADDITIONALLY, A CUT DOWN OF A CLOT IN THE COMMON FEMORAL WAS PERFORMED. THE HYPOTUBE WAS ABLE TO BE REMOVED FROM THE COMMON FEMORAL DURING THIS TIME, HOWEVER, THE RUPTURED COMPONENTS REMAINED IN-VIVO. THE PHYSICIAN ATTEMPTED TO RETRIEVE THE COMPONENTS; HOWEVER, THEY WERE DIFFICULT TO BE IDENTIFIED WITH ANGIOGRAPHIC IMAGING AND THEREFORE, STENTS WERE PLACED IN THE AREA WHERE THE BALLOON RUPTURED. THE PHYSICIAN BELIEVED THE STENTS WERE ABLE TO COVER THE RUPTURED COMPONENT. AT THE END OF THE PROCEDURE, IT WAS INDICATED THAT THE FLOW WAS SUFFICIENT AND THE PROCEDURE WAS COMPLETED. THE PATIENT WAS IN STABLE CONDITION.
Patient problems: Foreign Body In Patient
MAUDE report 21775326 ↗MalfunctionMar 29, 2025Material Split, Cut or Torn; Material Split, Cut or Torn
IT WAS REPORTED THAT A NON-DILATABLE, HEAVILY CALCIFIED, HEAVILY TORTUOUS SUPERFICIAL FEMORAL ARTERY WITH CHRONIC TOTAL OCCLUSION WAS ATTEMPTED TO BE TREATED WITH SEVERAL UNSPECIFIED BALLOONS, ALL UNSUCCESSFULLY. WHEN A JADE PTA OTW 5 X 150 MM BALLOON WAS ATTEMPTED TO BE USED, IT RUPTURED WHEN IT REACHED ROUGHLY 22-24 ATMOSPHERES. THE RUPTURED COMPONENT CAME ENTIRELY OFF THE SHAFT. THERE WAS A DELAY OF A FEW HOURS WHILE THE PHYSICIAN PLACED STENTS. ADDITIONALLY, A CUT DOWN OF A CLOT IN THE COMMON FEMORAL WAS PERFORMED. THE HYPOTUBE WAS ABLE TO BE REMOVED FROM THE COMMON FEMORAL DURING THIS TIME, HOWEVER, THE RUPTURED COMPONENTS REMAINED IN-VIVO. THE PHYSICIAN ATTEMPTED TO RETRIEVE THE COMPONENTS; HOWEVER, THEY WERE DIFFICULT TO BE IDENTIFIED WITH ANGIOGRAPHIC IMAGING AND THEREFORE, STENTS WERE PLACED IN THE AREA WHERE THE BALLOON RUPTURED. THE PHYSICIAN BELIEVED THE STENTS WERE ABLE TO COVER THE RUPTURED COMPONENT. AT THE END OF THE PROCEDURE, IT WAS INDICATED THAT THE FLOW WAS SUFFICIENT AND THE PROCEDURE WAS COMPLETED. THE PATIENT WAS IN STABLE CONDITION. NO CASE IMAGE/CD AND OTHER INFORMATION WAS PROVIDED FOR ANALYSIS.
Patient problems: Foreign Body In Patient
MAUDE report 21728429 ↗
Other Catheter, Angioplasty, Peripheral, Transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page